Besides, the presence of CD44+ cancer cells at the invasive front of gastric tumors is associated with poor prognosis [99], and the presence of circulating CD44+ tumor cells in patients correlates with tumor stage and depth, vascular invasion, metastasis and reduced survival [100,101]. This evidence concerns the gene CD44 and cancer.